NCT04905537 Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness
| NCT ID | NCT04905537 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Fudan University |
| Condition | Genetic Screening |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2021-01-01 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The researchers hope to establish an overall program of early genetic screening for neonatal critical illness in China, and to develop precise intervention strategies to assist clinical diagnosis and treatment of hereditary critical illness.
Eligibility Criteria
Inclusion Criteria: * Postnatal age less than 100 days; * Perinatal death after 20 weeks of gestation (more than 500 g) * Can be retained biological samples for genetic screening; * Biological parent or guardian's informed consent. Exclusion Criteria: * Reluctance of parents to use genetic sequencing data for subsequent research; * Parents under 18 years of age or incapacitated for decision-making; * subjects older than 100 days; * Perinatal death less than 20 weeks of gestation or weight less than 500 g; * Inherited metabolic diseases with chromosomal abnormalities; * Multiple pregnancies; * Lack of access to biological samples from which DNA can be extracted; * Failure to sign informed consent.
Contact & Investigator
Wenhao Zhou
STUDY CHAIR
Children's Hospital of Fudan University
Frequently Asked Questions
Who can join the NCT04905537 clinical trial?
This trial is open to participants of all sexes, up to 100 Days, studying Genetic Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04905537 currently recruiting?
Yes, NCT04905537 is actively recruiting participants. Contact the research team at zhouwenhao@fudan.edu.cn for enrollment information.
Where is the NCT04905537 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT04905537 clinical trial?
NCT04905537 is sponsored by Children's Hospital of Fudan University. The principal investigator is Wenhao Zhou at Children's Hospital of Fudan University. The trial plans to enroll 4,000 participants.